Kemper believes that Consolidated Net Operating Income provides investors with a valuable measure of its ongoing performance because it reveals underlying operational performance trends that otherwise might be less apparent if the items were not excluded. Net realized gains (losses) on sales of investments and net impairment losses recognized in earnings related to investments included in Kemper’s results may vary significantly between periods and are generally driven by business decisions and external economic developments such as capital market conditions that impact the values of the company’s investments, the timing of which is unrelated to the insurance underwriting process. Significant non-recurring items are excluded because, by their nature, they are not indicative of Kemper’s business or economic trends.
A reconciliation of Consolidated Net Operating Income to Income from Continuing Operations for the three and nine months ended September 30, 2012 and 2011 is presented below:
|Three Months Ended||Nine Months Ended|
|(Dollars in Millions) (Unaudited)||Sep 30,2012||Sep 30,2011||Sep 30,2012||Sep 30,2011|
|Consolidated Net Operating Income||$||24.6||$||7.1||$||57.2||$||23.0|
|Net Income (Loss) From:|
|Net Realized Gains (Losses) on Sales of Investments||33.0||(2.7||)||38.9||18.0|
|Net Impairment Losses Recognized in Earnings||(2.0||)||(3.3||)||(2.6||)||(4.3||)|
|Income from Continuing Operations||$||55.6||$||1.1||$||93.5||$||36.7|
Consolidated Net Operating Income Per Unrestricted Share
Consolidated Net Operating Income Per Unrestricted Share is a non-GAAP financial measure computed by dividing Consolidated Net Operating Income by the weighted average unrestricted shares outstanding. The most directly comparable GAAP financial measure is Income from Continuing Operations Per Unrestricted share‐basic.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts